Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Effectiveness of pegylated interferon alfa 2a and ribavirin for chronic hepatitis C in clinical practice].

Acta gastroenterologica Latinoamericana - 1 Jun 2010

Hernández Nelia, Mescia Germán, Pollio Carmen, Robaina Gabriela, Quintana Laura, Bianchi Carla

Abstract excerpt

BACKGROUND: Nowadays, combination therapy with peginteferon plus ribavirin is the standard treatment for chronic hepatitis C. This scheme achieves, according to randomized and controlled trials, viral eradication in 54% to 56% of treated patients (42% to 46% of patients infected with genotype 1 a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Polyethylene Glycols

Share to Ribavirin

Share to Viral Load

Source

Identifiers

PMID: 20645558

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20645558-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Effectiveness of pegylated interferon alfa 2a and ribavirin for chronic hepatitis C in clinical practice].PMID 20645558Read ↗

[Efficacy of combination treatment with pegylated interferon plus ribavirin in patients chronically infected with HCV].Semantic proximity Read ↗

[Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients living in Daejeon and Chungcheong Province in Korea: a comparative study].Semantic proximity Read ↗

[Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C].Semantic proximity Read ↗

[Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection].Semantic proximity Read ↗

[Treatment of chronic hepatitis viral C: new associations].Semantic proximity Read ↗

[Efficacy of peginterferon and ribavirin combination therapy of chronic hepatitis C: a pooled analysis].Semantic proximity Read ↗

[Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C].Semantic proximity Read ↗

[Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection].Semantic proximity Read ↗

[Interferon-alpha and ribavirin therapy on chronic hepatitis C virus infection: the experience of Rio Grande do Sul State Health Department, Brazil].Semantic proximity Read ↗

Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

[Effectiveness of long-acting interferon (peginterferon)].Semantic proximity Read ↗

[Effectiveness and complications of combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis C].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.